Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $90.88 | $23.31 | 289.80% | 197.57x | 152.30x | 12.34x | 15.29x | 1.41x | $119.79M | 1.26% | $637.99M | 6.11 | $9.66B | -1,406.50 | ||
| LQDA | LIQUIDIA CORP | $87.04 | $17.02 | 411.28% | 362.67x | 26.20x | 26.59x | 71.29x | 1.79x | $41.15M | 0.54% | $108.58M | 1.23 | $7.70B | 143.72 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $266.99 | $91.71 | 191.12% | 61.24x | 35.54x | 8.28x | 33.15x | 1.25x | $641.34M | 1.81% | $1.08B | 8.09 | $36.91B | 39.92 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.38 | $2.72 | 207.60% | 119.71x | 74.69x | 4.54x | 111.19x | 1.15x | $47.52M | 3.33% | $13.01M | 0.08 | $1.59B | 29.82 | ||
| KRYS | KRYSTAL BIOTECH INC | $336.80 | $91.73 | 267.18% | 43.46x | 43.41x | 23.64x | 7.78x | 2.09x | $237.38M | 2.41% | $1.28B | 43.59 | $9.44B | 44.10 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $62.44 | $16.72 | 273.40% | 63.71x | 48.91x | 6.34x | 7.93x | 1.73x | $164.23M | 3.44% | $605.69M | 7.92 | $4.62B | 41.47 | ||
| ADMA | ADMA BIOLOGICS INC | $8.38 | $8.88 | -5.67% | 12.14x | 9.99x | 3.88x | 4.98x | 0.51x | $107.90M | 5.45% | $390.33M | 1.65 | $2.00B | 9.04 | ||
| HALO | HALOZYME THERAPEUTICS INC | $77.82 | $68.84 | 13.04% | 26.29x | 9.37x | 6.09x | 42.03x | 0.47x | $667.65M | 7.26% | $219.64M | 1.86 | $11.06B | 17.73 | ||
| RPRX | ROYALTY PHARMA PLC | $58.72 | $39.21 | 49.76% | 30.74x | 10.94x | 10.51x | 3.40x | 0.65x | $2.34B | 9.13% | $9.94B | 22.75 | $42.18B | 36.26 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.40 | $37.81 | 54.46% | 41.71x | 15.81x | 3.47x | 1.82x | 0.62x | $767.06M | 6.82% | $6.21B | 32.27 | $9.65B | 19.99 | ||
| VCEL | VERICEL CORP | $44.56 | $8.82 | 405.20% | 103.63x | 92.43x | 7.75x | 6.39x | 2.18x | $47.49M | 2.10% | $356.23M | 7.02 | $2.26B | 55.94 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $304.26 | $94.97 | 220.39% | 38.51x | 33.22x | 22.04x | 6.11x | 1.80x | $122.22M | 2.02% | $997.32M | 50.16 | $6.43B | 28.53 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $250.41 | $47.53 | 426.87% | 532.79x | 9.67x | 3.49x | 3.47x | 1.80x | $1.30B | 8.37% | $4.53B | 73.22 | $19.27B | 28.55 | ||
| ASND | ASCENDIS PHARMA A | $251.93 | $77.57 | 224.78% | 26.70x | 17.32x | 15.36x | 27.26x | 2.76x | $52.94M | 0.34% | $574.09M | 9.24 | $16.03B | 171.88 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.86 | $34.44 | 1.22% | 13.78x | 9.27x | 2.24x | 2.22x | 0.52x | $341.79M | 16.96% | $910.35M | 15.75 | $1.59B | 6.70 | ||
| TECH | BIO-TECHNE CORP | $71.78 | $16.17 | 343.90% | 101.10x | 34.40x | 9.27x | 5.39x | 1.85x | $269.60M | 2.40% | $2.09B | 13.34 | $11.32B | 44.22 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.27 | $8.67 | -85.35% | 4.70x | -4.29x | 1.19x | 1.39x | 0.06x | $7.24M | 9.92% | $52.93M | 0.92 | $19.88M | 1.28 | ||
| TGTX | TG THERAPEUTICS INC | $52.68 | $21.03 | 150.46% | 16.36x | 37.32x | 10.86x | 13.83x | 3.67x | -$14.19M | -0.19% | $583.13M | 4.04 | $8.37B | 55.82 | ||
| UTHR | UNITED THERAPEUTICS CORP | $527.07 | $231.72 | 127.46% | 18.00x | 19.31x | 7.23x | 3.79x | 2.07x | $1.02B | 4.44% | $5.90B | 135.66 | $21.09B | 12.31 | ||
| EXEL | EXELIXIS INC | $54.98 | $30.02 | 83.15% | 17.62x | 16.87x | 5.98x | 7.14x | 1.26x | $917.69M | 6.46% | $1.94B | 7.49 | $13.76B | 13.03 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $472.57 | $161.04 | 193.45% | 27.78x | 24.44x | 9.83x | 6.19x | 2.06x | $3.71B | 3.09% | $19.36B | 76.20 | $116.43B | 21.59 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.40 | $2.05 | 65.49% | 14.15x | 14.58x | 2.08x | 3.28x | 1.33x | $4.11M | 1.50% | $82.33M | 1.03 | $206.42M | 9.72 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $651.18 | $419.38 | 55.27% | 15.30x | 13.93x | 4.54x | 2.17x | 1.04x | $4.11B | 6.07% | $31.42B | 302.15 | $68.01B | 11.84 | ||
| VCYT | VERACYTE INC | $58.01 | $8.70 | 566.47% | 52.26x | 52.31x | 8.52x | 3.44x | 6.15x | $155.34M | 3.37% | $1.34B | 16.90 | $4.40B | 38.27 | ||
| INCY | INCYTE CORP | $115.79 | $63.66 | 81.89% | 15.88x | 14.53x | 4.31x | 4.11x | 1.41x | $1.45B | 6.29% | $5.62B | 28.21 | $19.70B | 10.53 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.